E. Eksioglu-Demiralp Et Al. , "Imatinib does not inhibit neutrophil oxidative burst function in patients with chronic myelogenous leukemia (CML).," 46th Annual Meeting of the American-Society-of-Hematology , vol.104, California, United States Of America, 2004
Eksioglu-Demiralp, E. Et Al. 2004. Imatinib does not inhibit neutrophil oxidative burst function in patients with chronic myelogenous leukemia (CML).. 46th Annual Meeting of the American-Society-of-Hematology , (California, United States Of America).
Eksioglu-Demiralp, E., Bizargity, P., Adiguzel, C., Ozilhan, G., & Bayik, M., (2004). Imatinib does not inhibit neutrophil oxidative burst function in patients with chronic myelogenous leukemia (CML). . 46th Annual Meeting of the American-Society-of-Hematology, California, United States Of America
Eksioglu-Demiralp, E Et Al. "Imatinib does not inhibit neutrophil oxidative burst function in patients with chronic myelogenous leukemia (CML).," 46th Annual Meeting of the American-Society-of-Hematology, California, United States Of America, 2004
Eksioglu-Demiralp, E Et Al. "Imatinib does not inhibit neutrophil oxidative burst function in patients with chronic myelogenous leukemia (CML).." 46th Annual Meeting of the American-Society-of-Hematology , California, United States Of America, 2004
Eksioglu-Demiralp, E. Et Al. (2004) . "Imatinib does not inhibit neutrophil oxidative burst function in patients with chronic myelogenous leukemia (CML).." 46th Annual Meeting of the American-Society-of-Hematology , California, United States Of America.
@conferencepaper{conferencepaper, author={E Eksioglu-Demiralp Et Al. }, title={Imatinib does not inhibit neutrophil oxidative burst function in patients with chronic myelogenous leukemia (CML).}, congress name={46th Annual Meeting of the American-Society-of-Hematology}, city={California}, country={United States Of America}, year={2004}}